Global Animal Model for Drug Testing Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Animal Model for Drug Testing Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 96

Published Date: 30 Jun 2021

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Animal Model for Drug Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Animal Model for Drug Testing size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Animal Model for Drug Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Animal Model for Drug Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Rats
Mice
Others

Market segment by Application can be divided into
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies

The key market players for global Animal Model for Drug Testing market are listed below:
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Animal Model for Drug Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Animal Model for Drug Testing, with price, sales, revenue and global market share of Animal Model for Drug Testing from 2019 to 2021.
Chapter 3, the Animal Model for Drug Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal Model for Drug Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Animal Model for Drug Testing market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Animal Model for Drug Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Animal Model for Drug Testing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Animal Model for Drug Testing Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Rats
1.2.3 Mice
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Animal Model for Drug Testing Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.4 Global Animal Model for Drug Testing Market Size & Forecast
1.4.1 Global Animal Model for Drug Testing Sales in Value (2016-2026))
1.4.2 Global Animal Model for Drug Testing Sales in Volume (2016-2026)
1.4.3 Global Animal Model for Drug Testing Price by Type (2016-2026) & (US$/Unit)
1.5 Global Animal Model for Drug Testing Production Capacity Analysis
1.5.1 Global Animal Model for Drug Testing Total Production Capacity (2016-2026)
1.5.2 Global Animal Model for Drug Testing Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal Model for Drug Testing Market Drivers
1.6.2 Animal Model for Drug Testing Market Restraints
1.6.3 Animal Model for Drug Testing Trends Analysis

2 Manufacturers Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business
2.1.3 Charles River Laboratories Animal Model for Drug Testing Product and Services
2.1.4 Charles River Laboratories Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Envigo
2.2.1 Envigo Details
2.2.2 Envigo Major Business
2.2.3 Envigo Animal Model for Drug Testing Product and Services
2.2.4 Envigo Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Taconic Biosciences
2.3.1 Taconic Biosciences Details
2.3.2 Taconic Biosciences Major Business
2.3.3 Taconic Biosciences Animal Model for Drug Testing Product and Services
2.3.4 Taconic Biosciences Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Jackson Laboratory
2.4.1 Jackson Laboratory Details
2.4.2 Jackson Laboratory Major Business
2.4.3 Jackson Laboratory Animal Model for Drug Testing Product and Services
2.4.4 Jackson Laboratory Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Crown Biosciences
2.5.1 Crown Biosciences Details
2.5.2 Crown Biosciences Major Business
2.5.3 Crown Biosciences Animal Model for Drug Testing Product and Services
2.5.4 Crown Biosciences Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Shanghai SLAC
2.6.1 Shanghai SLAC Details
2.6.2 Shanghai SLAC Major Business
2.6.3 Shanghai SLAC Animal Model for Drug Testing Product and Services
2.6.4 Shanghai SLAC Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Shangghai Modelorg
2.7.1 Shangghai Modelorg Details
2.7.2 Shangghai Modelorg Major Business
2.7.3 Shangghai Modelorg Animal Model for Drug Testing Product and Services
2.7.4 Shangghai Modelorg Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 GenOway
2.8.1 GenOway Details
2.8.2 GenOway Major Business
2.8.3 GenOway Animal Model for Drug Testing Product and Services
2.8.4 GenOway Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Syngene International
2.9.1 Syngene International Details
2.9.2 Syngene International Major Business
2.9.3 Syngene International Animal Model for Drug Testing Product and Services
2.9.4 Syngene International Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Psychogenics
2.10.1 Psychogenics Details
2.10.2 Psychogenics Major Business
2.10.3 Psychogenics Animal Model for Drug Testing Product and Services
2.10.4 Psychogenics Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Pharmaron
2.11.1 Pharmaron Details
2.11.2 Pharmaron Major Business
2.11.3 Pharmaron Animal Model for Drug Testing Product and Services
2.11.4 Pharmaron Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Pharmalegacy
2.12.1 Pharmalegacy Details
2.12.2 Pharmalegacy Major Business
2.12.3 Pharmalegacy Animal Model for Drug Testing Product and Services
2.12.4 Pharmalegacy Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Vitalstar Biotechnology
2.13.1 Vitalstar Biotechnology Details
2.13.2 Vitalstar Biotechnology Major Business
2.13.3 Vitalstar Biotechnology Animal Model for Drug Testing Product and Services
2.13.4 Vitalstar Biotechnology Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Animal Model for Drug Testing Sales by Manufacturer
3.1 Global Animal Model for Drug Testing Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Animal Model for Drug Testing Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Animal Model for Drug Testing
3.4 Market Concentration Rate
3.4.1 Top 3 Animal Model for Drug Testing Manufacturer Market Share
3.4.2 Top 6 Animal Model for Drug Testing Manufacturer Market Share
3.5 Global Animal Model for Drug Testing Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Animal Model for Drug Testing Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Animal Model for Drug Testing Market Size by Region
4.1.1 Global Animal Model for Drug Testing Sales in Volume by Region (2016-2026)
4.1.2 Global Animal Model for Drug Testing Revenue by Region (2016-2026)
4.2 North America Animal Model for Drug Testing Revenue (2016-2026)
4.3 Europe Animal Model for Drug Testing Revenue (2016-2026)
4.4 Asia-Pacific Animal Model for Drug Testing Revenue (2016-2026)
4.5 South America Animal Model for Drug Testing Revenue (2016-2026)
4.6 Middle East and Africa Animal Model for Drug Testing Revenue (2016-2026)

5 Market Segment by Type
5.1 Global Animal Model for Drug Testing Sales in Volume by Type (2016-2026)
5.2 Global Animal Model for Drug Testing Revenue by Type (2016-2026)
5.3 Global Animal Model for Drug Testing Price by Type (2016-2026)

6 Market Segment by Application
6.1 Global Animal Model for Drug Testing Sales in Volume by Application (2016-2026)
6.2 Global Animal Model for Drug Testing Revenue by Application (2016-2026)
6.3 Global Animal Model for Drug Testing Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
7.1 North America Animal Model for Drug Testing Sales by Type (2016-2026)
7.2 North America Animal Model for Drug Testing Sales by Application (2016-2026)
7.3 North America Animal Model for Drug Testing Market Size by Country
7.3.1 North America Animal Model for Drug Testing Sales in Volume by Country (2016-2026)
7.3.2 North America Animal Model for Drug Testing Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
8.1 Europe Animal Model for Drug Testing Sales by Type (2016-2026)
8.2 Europe Animal Model for Drug Testing Sales by Application (2016-2026)
8.3 Europe Animal Model for Drug Testing Market Size by Country
8.3.1 Europe Animal Model for Drug Testing Sales in Volume by Country (2016-2026)
8.3.2 Europe Animal Model for Drug Testing Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Animal Model for Drug Testing Sales by Type (2016-2026)
9.2 Asia-Pacific Animal Model for Drug Testing Sales by Application (2016-2026)
9.3 Asia-Pacific Animal Model for Drug Testing Market Size by Region
9.3.1 Asia-Pacific Animal Model for Drug Testing Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Animal Model for Drug Testing Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
10.1 South America Animal Model for Drug Testing Sales by Type (2016-2026)
10.2 South America Animal Model for Drug Testing Sales by Application (2016-2026)
10.3 South America Animal Model for Drug Testing Market Size by Country
10.3.1 South America Animal Model for Drug Testing Sales in Volume by Country (2016-2026)
10.3.2 South America Animal Model for Drug Testing Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Animal Model for Drug Testing Sales by Type (2016-2026)
11.2 Middle East & Africa Animal Model for Drug Testing Sales by Application (2016-2026)
11.3 Middle East & Africa Animal Model for Drug Testing Market Size by Country
11.3.1 Middle East & Africa Animal Model for Drug Testing Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Animal Model for Drug Testing Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Animal Model for Drug Testing Typical Distributors
12.3 Animal Model for Drug Testing Typical Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Animal Model for Drug Testing Revenue by Type, (USD Million), 2021-2026
Table 2. Global Animal Model for Drug Testing Revenue by Application, (USD Million), 2021-2026
Table 3. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Charles River Laboratories Major Business
Table 5. Charles River Laboratories Animal Model for Drug Testing Product and Services
Table 6. Charles River Laboratories Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Envigo Basic Information, Manufacturing Base and Competitors
Table 8. Envigo Major Business
Table 9. Envigo Animal Model for Drug Testing Product and Services
Table 10. Envigo Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Taconic Biosciences Basic Information, Manufacturing Base and Competitors
Table 12. Taconic Biosciences Major Business
Table 13. Taconic Biosciences Animal Model for Drug Testing Product and Services
Table 14. Taconic Biosciences Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Jackson Laboratory Basic Information, Manufacturing Base and Competitors
Table 16. Jackson Laboratory Major Business
Table 17. Jackson Laboratory Animal Model for Drug Testing Product and Services
Table 18. Jackson Laboratory Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Crown Biosciences Basic Information, Manufacturing Base and Competitors
Table 20. Crown Biosciences Major Business
Table 21. Crown Biosciences Animal Model for Drug Testing Product and Services
Table 22. Crown Biosciences Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Shanghai SLAC Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai SLAC Major Business
Table 25. Shanghai SLAC Animal Model for Drug Testing Product and Services
Table 26. Shanghai SLAC Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Shangghai Modelorg Basic Information, Manufacturing Base and Competitors
Table 28. Shangghai Modelorg Major Business
Table 29. Shangghai Modelorg Animal Model for Drug Testing Product and Services
Table 30. Shangghai Modelorg Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GenOway Basic Information, Manufacturing Base and Competitors
Table 32. GenOway Major Business
Table 33. GenOway Animal Model for Drug Testing Product and Services
Table 34. GenOway Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Syngene International Basic Information, Manufacturing Base and Competitors
Table 36. Syngene International Major Business
Table 37. Syngene International Animal Model for Drug Testing Product and Services
Table 38. Syngene International Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Psychogenics Basic Information, Manufacturing Base and Competitors
Table 40. Psychogenics Major Business
Table 41. Psychogenics Animal Model for Drug Testing Product and Services
Table 42. Psychogenics Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Pharmaron Basic Information, Manufacturing Base and Competitors
Table 44. Pharmaron Major Business
Table 45. Pharmaron Animal Model for Drug Testing Product and Services
Table 46. Pharmaron Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Pharmalegacy Basic Information, Manufacturing Base and Competitors
Table 48. Pharmalegacy Major Business
Table 49. Pharmalegacy Animal Model for Drug Testing Product and Services
Table 50. Pharmalegacy Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Vitalstar Biotechnology Basic Information, Manufacturing Base and Competitors
Table 52. Vitalstar Biotechnology Major Business
Table 53. Vitalstar Biotechnology Animal Model for Drug Testing Product and Services
Table 54. Vitalstar Biotechnology Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Animal Model for Drug Testing Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Animal Model for Drug Testing Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Animal Model for Drug Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Animal Model for Drug Testing Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Animal Model for Drug Testing Production Site of Key Manufacturer
Table 60. Animal Model for Drug Testing New Entrant and Capacity Expansion Plans
Table 61. Animal Model for Drug Testing Mergers & Acquisitions in the Past Five Years
Table 62. Global Animal Model for Drug Testing Sales by Region (2016-2021e) & (K Units)
Table 63. Global Animal Model for Drug Testing Sales by Region (2021-2026) & (K Units)
Table 64. Global Animal Model for Drug Testing Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Animal Model for Drug Testing Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 67. Global Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 68. Global Animal Model for Drug Testing Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Animal Model for Drug Testing Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Animal Model for Drug Testing Price by Type (2016-2021e) & (US$/Unit)
Table 71. Global Animal Model for Drug Testing Price by Type (2021-2026) & (US$/Unit)
Table 72. Global Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 73. Global Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 74. Global Animal Model for Drug Testing Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Animal Model for Drug Testing Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Animal Model for Drug Testing Price by Application (2016-2021e) & (US$/Unit)
Table 77. Global Animal Model for Drug Testing Price by Application (2021-2026) & (US$/Unit)
Table 78. North America Animal Model for Drug Testing Sales by Country (2016-2021e) & (K Units)
Table 79. North America Animal Model for Drug Testing Sales by Country (2021-2026) & (K Units)
Table 80. North America Animal Model for Drug Testing Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Animal Model for Drug Testing Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 83. North America Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 84. North America Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 85. North America Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 86. Europe Animal Model for Drug Testing Sales by Country (2016-2021e) & (K Units)
Table 87. Europe Animal Model for Drug Testing Sales by Country (2021-2026) & (K Units)
Table 88. Europe Animal Model for Drug Testing Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Animal Model for Drug Testing Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 91. Europe Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 92. Europe Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 93. Europe Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 94. Asia-Pacific Animal Model for Drug Testing Sales by Region (2016-2021e) & (K Units)
Table 95. Asia-Pacific Animal Model for Drug Testing Sales by Region (2021-2026) & (K Units)
Table 96. Asia-Pacific Animal Model for Drug Testing Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Animal Model for Drug Testing Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 99. Asia-Pacific Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 100. Asia-Pacific Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 101. Asia-Pacific Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 102. South America Animal Model for Drug Testing Sales by Country (2016-2021e) & (K Units)
Table 103. South America Animal Model for Drug Testing Sales by Country (2021-2026) & (K Units)
Table 104. South America Animal Model for Drug Testing Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Animal Model for Drug Testing Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 107. South America Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 108. South America Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 109. South America Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 110. Middle East & Africa Animal Model for Drug Testing Sales by Country (2016-2021e) & (K Units)
Table 111. Middle East & Africa Animal Model for Drug Testing Sales by Country (2021-2026) & (K Units)
Table 112. Middle East & Africa Animal Model for Drug Testing Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Animal Model for Drug Testing Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 115. Middle East & Africa Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 116. Middle East & Africa Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 117. Middle East & Africa Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Animal Model for Drug Testing Typical Distributors
Table 121. Animal Model for Drug Testing Typical Customers
List of Figures
Figure 1. Animal Model for Drug Testing Picture
Figure 2. Global Animal Model for Drug Testing Sales Market Share by Type in 2020
Figure 3. Rats
Figure 4. Mice
Figure 5. Others
Figure 6. Global Animal Model for Drug Testing Sales Market Share by Application in 2020
Figure 7. Academic and Research Institutes
Figure 8. Pharmaceutical and Biotechnology Companies
Figure 9. Global Animal Model for Drug Testing Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Animal Model for Drug Testing Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Animal Model for Drug Testing Sales (2016-2026) & (K Units)
Figure 12. Global Animal Model for Drug Testing Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Animal Model for Drug Testing Production Capacity (2016-2026) & (K Units)
Figure 14. Global Animal Model for Drug Testing Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Animal Model for Drug Testing Market Drivers
Figure 16. Animal Model for Drug Testing Market Restraints
Figure 17. Animal Model for Drug Testing Market Trends
Figure 18. Global Animal Model for Drug Testing Sales Market Share by Manufacturer in 2020
Figure 19. Global Animal Model for Drug Testing Revenue Market Share by Manufacturer in 2020
Figure 20. Animal Model for Drug Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Animal Model for Drug Testing Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Animal Model for Drug Testing Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Animal Model for Drug Testing Sales Market Share by Region (2016-2026)
Figure 24. Global Animal Model for Drug Testing Revenue Market Share by Region (2016-2026)
Figure 25. North America Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 26. Europe Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 28. South America Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 30. Global Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 31. Global Animal Model for Drug Testing Revenue Market Share by Type (2016-2026)
Figure 32. Global Animal Model for Drug Testing Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 34. Global Animal Model for Drug Testing Revenue Market Share by Application (2016-2026)
Figure 35. Global Animal Model for Drug Testing Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 37. North America Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 38. North America Animal Model for Drug Testing Sales Market Share by Country (2016-2026)
Figure 39. North America Animal Model for Drug Testing Revenue Market Share by Country (2016-2026)
Figure 40. United States Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 44. Europe Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 45. Europe Animal Model for Drug Testing Sales Market Share by Country (2016-2026)
Figure 46. Europe Animal Model for Drug Testing Revenue Market Share by Country (2016-2026)
Figure 47. Germany Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Animal Model for Drug Testing Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Animal Model for Drug Testing Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Animal Model for Drug Testing Revenue Market Share by Region (2016-2026)
Figure 56. China Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 63. South America Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 64. South America Animal Model for Drug Testing Sales Market Share by Country (2016-2026)
Figure 65. South America Animal Model for Drug Testing Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Animal Model for Drug Testing Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Animal Model for Drug Testing Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Animal Model for Drug Testing Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Animal Model for Drug Testing Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 96

Published Date: 30 Jun 2021

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Animal Model for Drug Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Animal Model for Drug Testing size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Animal Model for Drug Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Animal Model for Drug Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Rats
Mice
Others

Market segment by Application can be divided into
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies

The key market players for global Animal Model for Drug Testing market are listed below:
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Animal Model for Drug Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Animal Model for Drug Testing, with price, sales, revenue and global market share of Animal Model for Drug Testing from 2019 to 2021.
Chapter 3, the Animal Model for Drug Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal Model for Drug Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Animal Model for Drug Testing market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Animal Model for Drug Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Animal Model for Drug Testing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Animal Model for Drug Testing Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Rats
1.2.3 Mice
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Animal Model for Drug Testing Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.4 Global Animal Model for Drug Testing Market Size & Forecast
1.4.1 Global Animal Model for Drug Testing Sales in Value (2016-2026))
1.4.2 Global Animal Model for Drug Testing Sales in Volume (2016-2026)
1.4.3 Global Animal Model for Drug Testing Price by Type (2016-2026) & (US$/Unit)
1.5 Global Animal Model for Drug Testing Production Capacity Analysis
1.5.1 Global Animal Model for Drug Testing Total Production Capacity (2016-2026)
1.5.2 Global Animal Model for Drug Testing Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal Model for Drug Testing Market Drivers
1.6.2 Animal Model for Drug Testing Market Restraints
1.6.3 Animal Model for Drug Testing Trends Analysis

2 Manufacturers Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business
2.1.3 Charles River Laboratories Animal Model for Drug Testing Product and Services
2.1.4 Charles River Laboratories Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Envigo
2.2.1 Envigo Details
2.2.2 Envigo Major Business
2.2.3 Envigo Animal Model for Drug Testing Product and Services
2.2.4 Envigo Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Taconic Biosciences
2.3.1 Taconic Biosciences Details
2.3.2 Taconic Biosciences Major Business
2.3.3 Taconic Biosciences Animal Model for Drug Testing Product and Services
2.3.4 Taconic Biosciences Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Jackson Laboratory
2.4.1 Jackson Laboratory Details
2.4.2 Jackson Laboratory Major Business
2.4.3 Jackson Laboratory Animal Model for Drug Testing Product and Services
2.4.4 Jackson Laboratory Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Crown Biosciences
2.5.1 Crown Biosciences Details
2.5.2 Crown Biosciences Major Business
2.5.3 Crown Biosciences Animal Model for Drug Testing Product and Services
2.5.4 Crown Biosciences Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Shanghai SLAC
2.6.1 Shanghai SLAC Details
2.6.2 Shanghai SLAC Major Business
2.6.3 Shanghai SLAC Animal Model for Drug Testing Product and Services
2.6.4 Shanghai SLAC Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Shangghai Modelorg
2.7.1 Shangghai Modelorg Details
2.7.2 Shangghai Modelorg Major Business
2.7.3 Shangghai Modelorg Animal Model for Drug Testing Product and Services
2.7.4 Shangghai Modelorg Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 GenOway
2.8.1 GenOway Details
2.8.2 GenOway Major Business
2.8.3 GenOway Animal Model for Drug Testing Product and Services
2.8.4 GenOway Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Syngene International
2.9.1 Syngene International Details
2.9.2 Syngene International Major Business
2.9.3 Syngene International Animal Model for Drug Testing Product and Services
2.9.4 Syngene International Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Psychogenics
2.10.1 Psychogenics Details
2.10.2 Psychogenics Major Business
2.10.3 Psychogenics Animal Model for Drug Testing Product and Services
2.10.4 Psychogenics Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Pharmaron
2.11.1 Pharmaron Details
2.11.2 Pharmaron Major Business
2.11.3 Pharmaron Animal Model for Drug Testing Product and Services
2.11.4 Pharmaron Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Pharmalegacy
2.12.1 Pharmalegacy Details
2.12.2 Pharmalegacy Major Business
2.12.3 Pharmalegacy Animal Model for Drug Testing Product and Services
2.12.4 Pharmalegacy Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Vitalstar Biotechnology
2.13.1 Vitalstar Biotechnology Details
2.13.2 Vitalstar Biotechnology Major Business
2.13.3 Vitalstar Biotechnology Animal Model for Drug Testing Product and Services
2.13.4 Vitalstar Biotechnology Animal Model for Drug Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Animal Model for Drug Testing Sales by Manufacturer
3.1 Global Animal Model for Drug Testing Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Animal Model for Drug Testing Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Animal Model for Drug Testing
3.4 Market Concentration Rate
3.4.1 Top 3 Animal Model for Drug Testing Manufacturer Market Share
3.4.2 Top 6 Animal Model for Drug Testing Manufacturer Market Share
3.5 Global Animal Model for Drug Testing Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Animal Model for Drug Testing Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Animal Model for Drug Testing Market Size by Region
4.1.1 Global Animal Model for Drug Testing Sales in Volume by Region (2016-2026)
4.1.2 Global Animal Model for Drug Testing Revenue by Region (2016-2026)
4.2 North America Animal Model for Drug Testing Revenue (2016-2026)
4.3 Europe Animal Model for Drug Testing Revenue (2016-2026)
4.4 Asia-Pacific Animal Model for Drug Testing Revenue (2016-2026)
4.5 South America Animal Model for Drug Testing Revenue (2016-2026)
4.6 Middle East and Africa Animal Model for Drug Testing Revenue (2016-2026)

5 Market Segment by Type
5.1 Global Animal Model for Drug Testing Sales in Volume by Type (2016-2026)
5.2 Global Animal Model for Drug Testing Revenue by Type (2016-2026)
5.3 Global Animal Model for Drug Testing Price by Type (2016-2026)

6 Market Segment by Application
6.1 Global Animal Model for Drug Testing Sales in Volume by Application (2016-2026)
6.2 Global Animal Model for Drug Testing Revenue by Application (2016-2026)
6.3 Global Animal Model for Drug Testing Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
7.1 North America Animal Model for Drug Testing Sales by Type (2016-2026)
7.2 North America Animal Model for Drug Testing Sales by Application (2016-2026)
7.3 North America Animal Model for Drug Testing Market Size by Country
7.3.1 North America Animal Model for Drug Testing Sales in Volume by Country (2016-2026)
7.3.2 North America Animal Model for Drug Testing Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
8.1 Europe Animal Model for Drug Testing Sales by Type (2016-2026)
8.2 Europe Animal Model for Drug Testing Sales by Application (2016-2026)
8.3 Europe Animal Model for Drug Testing Market Size by Country
8.3.1 Europe Animal Model for Drug Testing Sales in Volume by Country (2016-2026)
8.3.2 Europe Animal Model for Drug Testing Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Animal Model for Drug Testing Sales by Type (2016-2026)
9.2 Asia-Pacific Animal Model for Drug Testing Sales by Application (2016-2026)
9.3 Asia-Pacific Animal Model for Drug Testing Market Size by Region
9.3.1 Asia-Pacific Animal Model for Drug Testing Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Animal Model for Drug Testing Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
10.1 South America Animal Model for Drug Testing Sales by Type (2016-2026)
10.2 South America Animal Model for Drug Testing Sales by Application (2016-2026)
10.3 South America Animal Model for Drug Testing Market Size by Country
10.3.1 South America Animal Model for Drug Testing Sales in Volume by Country (2016-2026)
10.3.2 South America Animal Model for Drug Testing Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Animal Model for Drug Testing Sales by Type (2016-2026)
11.2 Middle East & Africa Animal Model for Drug Testing Sales by Application (2016-2026)
11.3 Middle East & Africa Animal Model for Drug Testing Market Size by Country
11.3.1 Middle East & Africa Animal Model for Drug Testing Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Animal Model for Drug Testing Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Animal Model for Drug Testing Typical Distributors
12.3 Animal Model for Drug Testing Typical Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Animal Model for Drug Testing Revenue by Type, (USD Million), 2021-2026
Table 2. Global Animal Model for Drug Testing Revenue by Application, (USD Million), 2021-2026
Table 3. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Charles River Laboratories Major Business
Table 5. Charles River Laboratories Animal Model for Drug Testing Product and Services
Table 6. Charles River Laboratories Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Envigo Basic Information, Manufacturing Base and Competitors
Table 8. Envigo Major Business
Table 9. Envigo Animal Model for Drug Testing Product and Services
Table 10. Envigo Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Taconic Biosciences Basic Information, Manufacturing Base and Competitors
Table 12. Taconic Biosciences Major Business
Table 13. Taconic Biosciences Animal Model for Drug Testing Product and Services
Table 14. Taconic Biosciences Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Jackson Laboratory Basic Information, Manufacturing Base and Competitors
Table 16. Jackson Laboratory Major Business
Table 17. Jackson Laboratory Animal Model for Drug Testing Product and Services
Table 18. Jackson Laboratory Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Crown Biosciences Basic Information, Manufacturing Base and Competitors
Table 20. Crown Biosciences Major Business
Table 21. Crown Biosciences Animal Model for Drug Testing Product and Services
Table 22. Crown Biosciences Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Shanghai SLAC Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai SLAC Major Business
Table 25. Shanghai SLAC Animal Model for Drug Testing Product and Services
Table 26. Shanghai SLAC Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Shangghai Modelorg Basic Information, Manufacturing Base and Competitors
Table 28. Shangghai Modelorg Major Business
Table 29. Shangghai Modelorg Animal Model for Drug Testing Product and Services
Table 30. Shangghai Modelorg Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GenOway Basic Information, Manufacturing Base and Competitors
Table 32. GenOway Major Business
Table 33. GenOway Animal Model for Drug Testing Product and Services
Table 34. GenOway Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Syngene International Basic Information, Manufacturing Base and Competitors
Table 36. Syngene International Major Business
Table 37. Syngene International Animal Model for Drug Testing Product and Services
Table 38. Syngene International Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Psychogenics Basic Information, Manufacturing Base and Competitors
Table 40. Psychogenics Major Business
Table 41. Psychogenics Animal Model for Drug Testing Product and Services
Table 42. Psychogenics Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Pharmaron Basic Information, Manufacturing Base and Competitors
Table 44. Pharmaron Major Business
Table 45. Pharmaron Animal Model for Drug Testing Product and Services
Table 46. Pharmaron Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Pharmalegacy Basic Information, Manufacturing Base and Competitors
Table 48. Pharmalegacy Major Business
Table 49. Pharmalegacy Animal Model for Drug Testing Product and Services
Table 50. Pharmalegacy Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Vitalstar Biotechnology Basic Information, Manufacturing Base and Competitors
Table 52. Vitalstar Biotechnology Major Business
Table 53. Vitalstar Biotechnology Animal Model for Drug Testing Product and Services
Table 54. Vitalstar Biotechnology Animal Model for Drug Testing Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Animal Model for Drug Testing Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Animal Model for Drug Testing Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Animal Model for Drug Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Animal Model for Drug Testing Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Animal Model for Drug Testing Production Site of Key Manufacturer
Table 60. Animal Model for Drug Testing New Entrant and Capacity Expansion Plans
Table 61. Animal Model for Drug Testing Mergers & Acquisitions in the Past Five Years
Table 62. Global Animal Model for Drug Testing Sales by Region (2016-2021e) & (K Units)
Table 63. Global Animal Model for Drug Testing Sales by Region (2021-2026) & (K Units)
Table 64. Global Animal Model for Drug Testing Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Animal Model for Drug Testing Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 67. Global Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 68. Global Animal Model for Drug Testing Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Animal Model for Drug Testing Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Animal Model for Drug Testing Price by Type (2016-2021e) & (US$/Unit)
Table 71. Global Animal Model for Drug Testing Price by Type (2021-2026) & (US$/Unit)
Table 72. Global Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 73. Global Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 74. Global Animal Model for Drug Testing Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Animal Model for Drug Testing Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Animal Model for Drug Testing Price by Application (2016-2021e) & (US$/Unit)
Table 77. Global Animal Model for Drug Testing Price by Application (2021-2026) & (US$/Unit)
Table 78. North America Animal Model for Drug Testing Sales by Country (2016-2021e) & (K Units)
Table 79. North America Animal Model for Drug Testing Sales by Country (2021-2026) & (K Units)
Table 80. North America Animal Model for Drug Testing Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Animal Model for Drug Testing Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 83. North America Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 84. North America Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 85. North America Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 86. Europe Animal Model for Drug Testing Sales by Country (2016-2021e) & (K Units)
Table 87. Europe Animal Model for Drug Testing Sales by Country (2021-2026) & (K Units)
Table 88. Europe Animal Model for Drug Testing Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Animal Model for Drug Testing Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 91. Europe Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 92. Europe Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 93. Europe Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 94. Asia-Pacific Animal Model for Drug Testing Sales by Region (2016-2021e) & (K Units)
Table 95. Asia-Pacific Animal Model for Drug Testing Sales by Region (2021-2026) & (K Units)
Table 96. Asia-Pacific Animal Model for Drug Testing Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Animal Model for Drug Testing Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 99. Asia-Pacific Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 100. Asia-Pacific Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 101. Asia-Pacific Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 102. South America Animal Model for Drug Testing Sales by Country (2016-2021e) & (K Units)
Table 103. South America Animal Model for Drug Testing Sales by Country (2021-2026) & (K Units)
Table 104. South America Animal Model for Drug Testing Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Animal Model for Drug Testing Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 107. South America Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 108. South America Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 109. South America Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 110. Middle East & Africa Animal Model for Drug Testing Sales by Country (2016-2021e) & (K Units)
Table 111. Middle East & Africa Animal Model for Drug Testing Sales by Country (2021-2026) & (K Units)
Table 112. Middle East & Africa Animal Model for Drug Testing Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Animal Model for Drug Testing Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Animal Model for Drug Testing Sales by Type (2016-2021e) & (K Units)
Table 115. Middle East & Africa Animal Model for Drug Testing Sales by Type (2021-2026) & (K Units)
Table 116. Middle East & Africa Animal Model for Drug Testing Sales by Application (2016-2021e) & (K Units)
Table 117. Middle East & Africa Animal Model for Drug Testing Sales by Application (2021-2026) & (K Units)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Animal Model for Drug Testing Typical Distributors
Table 121. Animal Model for Drug Testing Typical Customers
List of Figures
Figure 1. Animal Model for Drug Testing Picture
Figure 2. Global Animal Model for Drug Testing Sales Market Share by Type in 2020
Figure 3. Rats
Figure 4. Mice
Figure 5. Others
Figure 6. Global Animal Model for Drug Testing Sales Market Share by Application in 2020
Figure 7. Academic and Research Institutes
Figure 8. Pharmaceutical and Biotechnology Companies
Figure 9. Global Animal Model for Drug Testing Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Animal Model for Drug Testing Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Animal Model for Drug Testing Sales (2016-2026) & (K Units)
Figure 12. Global Animal Model for Drug Testing Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Animal Model for Drug Testing Production Capacity (2016-2026) & (K Units)
Figure 14. Global Animal Model for Drug Testing Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Animal Model for Drug Testing Market Drivers
Figure 16. Animal Model for Drug Testing Market Restraints
Figure 17. Animal Model for Drug Testing Market Trends
Figure 18. Global Animal Model for Drug Testing Sales Market Share by Manufacturer in 2020
Figure 19. Global Animal Model for Drug Testing Revenue Market Share by Manufacturer in 2020
Figure 20. Animal Model for Drug Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Animal Model for Drug Testing Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Animal Model for Drug Testing Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Animal Model for Drug Testing Sales Market Share by Region (2016-2026)
Figure 24. Global Animal Model for Drug Testing Revenue Market Share by Region (2016-2026)
Figure 25. North America Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 26. Europe Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 28. South America Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Animal Model for Drug Testing Revenue (2016-2026) & (USD Million)
Figure 30. Global Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 31. Global Animal Model for Drug Testing Revenue Market Share by Type (2016-2026)
Figure 32. Global Animal Model for Drug Testing Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 34. Global Animal Model for Drug Testing Revenue Market Share by Application (2016-2026)
Figure 35. Global Animal Model for Drug Testing Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 37. North America Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 38. North America Animal Model for Drug Testing Sales Market Share by Country (2016-2026)
Figure 39. North America Animal Model for Drug Testing Revenue Market Share by Country (2016-2026)
Figure 40. United States Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 44. Europe Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 45. Europe Animal Model for Drug Testing Sales Market Share by Country (2016-2026)
Figure 46. Europe Animal Model for Drug Testing Revenue Market Share by Country (2016-2026)
Figure 47. Germany Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Animal Model for Drug Testing Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Animal Model for Drug Testing Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Animal Model for Drug Testing Revenue Market Share by Region (2016-2026)
Figure 56. China Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 63. South America Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 64. South America Animal Model for Drug Testing Sales Market Share by Country (2016-2026)
Figure 65. South America Animal Model for Drug Testing Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Animal Model for Drug Testing Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Animal Model for Drug Testing Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Animal Model for Drug Testing Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Animal Model for Drug Testing Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Animal Model for Drug Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now